Literature DB >> 27270423

miR-374a-CCND1-pPI3K/AKT-c-JUN feedback loop modulated by PDCD4 suppresses cell growth, metastasis, and sensitizes nasopharyngeal carcinoma to cisplatin.

Y Zhen1,2,3, W Fang1,3, M Zhao3, R Luo1, Y Liu3, Q Fu3, Y Chen3, C Cheng3, Y Zhang4, Z Liu3,4.   

Abstract

miR-374a has been reported to function as an oncogene during tumor pathogenesis. In this study, miR-374a is observed to reduce nasopharyngeal carcinoma (NPC) cell proliferation, migration, invasion, metastasis and cisplatin (DDP) resistance in vitro and in vivo. Mechanistic analyses indicate that miR-374a directly targets CCND1 to inactivate pPI3K/pAKT/c-JUN forming a negative feedback loop, as well as suppressing downstream signals related to cell cycle progression and epithelial-mesenchymal transition (EMT). Interestingly, we also observed that miR-374a direct targeting of CCND1 is modulated by tumor suppressor PDCD4 via suppressing pPI3K/pAKT/c-JUN signaling. In clinical specimens, miR-374a was positively and negatively correlated with expression of PDCD4 and CCND1, respectively. Our studies are the first to demonstrate that the miR-374a-CCND1-pPI3K/AKT-c-JUN feedback loop induced by PDCD4 supresses NPC cell growth, metastasis and chemotherapy resistance.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27270423     DOI: 10.1038/onc.2016.201

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  37 in total

1.  Cyclin D1/cyclin-dependent kinase 4 interacts with filamin A and affects the migration and invasion potential of breast cancer cells.

Authors:  Zhijiu Zhong; Wen-Shuz Yeow; Chunhua Zou; Richard Wassell; Chenguang Wang; Richard G Pestell; Judy N Quong; Andrew A Quong
Journal:  Cancer Res       Date:  2010-02-23       Impact factor: 12.701

2.  Epithelial-mesenchymal status renders differential responses to cisplatin in ovarian cancer.

Authors:  Q H Miow; T Z Tan; J Ye; J A Lau; T Yokomizo; J-P Thiery; S Mori
Journal:  Oncogene       Date:  2014-05-26       Impact factor: 9.867

3.  EBV-miR-BART7-3p promotes the EMT and metastasis of nasopharyngeal carcinoma cells by suppressing the tumor suppressor PTEN.

Authors:  L-M Cai; X-M Lyu; W-R Luo; X-F Cui; Y-F Ye; C-C Yuan; Q-X Peng; D-H Wu; T-F Liu; E Wang; F-M Marincola; K-T Yao; W-Y Fang; H-B Cai; X Li
Journal:  Oncogene       Date:  2014-10-27       Impact factor: 9.867

Review 4.  Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways.

Authors:  Lionel Larue; Alfonso Bellacosa
Journal:  Oncogene       Date:  2005-11-14       Impact factor: 9.867

5.  Decreased miRNA-637 is an unfavorable prognosis marker and promotes glioma cell growth, migration and invasion via direct targeting Akt1.

Authors:  T Que; Y Song; Z Liu; S Zheng; H Long; Z Li; Y Liu; G Wang; Y Liu; J Zhou; X Zhang; W Fang; S Qi
Journal:  Oncogene       Date:  2015-01-19       Impact factor: 9.867

6.  Effects of differential distribution of microvessel density, possibly regulated by miR-374a, on breast cancer prognosis.

Authors:  Jian-Yi Li; Yang Zhang; Wen-Hai Zhang; Shi Jia; Ye Kang; Rui Tian
Journal:  Asian Pac J Cancer Prev       Date:  2013

7.  Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis.

Authors:  Olubunmi Afonja; Dominique Juste; Sharmistha Das; Sachiko Matsuhashi; Herbert H Samuels
Journal:  Oncogene       Date:  2004-10-21       Impact factor: 9.867

8.  Glucocorticoids mediate induction of microRNA-708 to suppress ovarian cancer metastasis through targeting Rap1B.

Authors:  Kai-Ti Lin; Yu-Ming Yeh; Chi-Mu Chuang; Scarlett Y Yang; Jer-Wei Chang; Shu-Pin Sun; Yi-Shiang Wang; Kuan-Chong Chao; Lu-Hai Wang
Journal:  Nat Commun       Date:  2015-01-08       Impact factor: 14.919

9.  miR-3188 regulates nasopharyngeal carcinoma proliferation and chemosensitivity through a FOXO1-modulated positive feedback loop with mTOR-p-PI3K/AKT-c-JUN.

Authors:  Mengyang Zhao; Rongcheng Luo; Yiyi Liu; Linyuan Gao; Zhaojian Fu; Qiaofen Fu; Xiaojun Luo; Yiyu Chen; Xiaojie Deng; Zixi Liang; Xin Li; Chao Cheng; Zhen Liu; Weiyi Fang
Journal:  Nat Commun       Date:  2016-04-20       Impact factor: 14.919

10.  miR-17-92 fine-tunes MYC expression and function to ensure optimal B cell lymphoma growth.

Authors:  Marija Mihailovich; Michael Bremang; Valeria Spadotto; Daniele Musiani; Elena Vitale; Gabriele Varano; Federico Zambelli; Francesco M Mancuso; David A Cairns; Giulio Pavesi; Stefano Casola; Tiziana Bonaldi
Journal:  Nat Commun       Date:  2015-11-10       Impact factor: 14.919

View more
  38 in total

1.  Elevation of MiR-9-3p suppresses the epithelial-mesenchymal transition of nasopharyngeal carcinoma cells via down-regulating FN1, ITGB1 and ITGAV.

Authors:  Yu Ding; Yinghua Pan; Shan Liu; Feng Jiang; Junbo Jiao
Journal:  Cancer Biol Ther       Date:  2017-06-14       Impact factor: 4.742

2.  miR-296-3p Negatively Regulated by Nicotine Stimulates Cytoplasmic Translocation of c-Myc via MK2 to Suppress Chemotherapy Resistance.

Authors:  Xiaojie Deng; Zhen Liu; Xiong Liu; Qiaofen Fu; Tongyuan Deng; Juan Lu; Yiyi Liu; Zixi Liang; Qingping Jiang; Chao Cheng; Weiyi Fang
Journal:  Mol Ther       Date:  2018-02-03       Impact factor: 11.454

Review 3.  The role of Pdcd4 in tumour suppression and protein translation.

Authors:  Qing Wang; Hsin-Sheng Yang
Journal:  Biol Cell       Date:  2018-05-28       Impact factor: 4.458

4.  c-Jun and Camk2a contribute to the drug resistance of induction docetaxel/cisplatin/5-fluorouracil in hypopharyngeal carcinoma.

Authors:  Shuzhou Liu; Meng Lian; Jugao Fang; Jie Zhai; Xixi Shen; Ru Wang
Journal:  Int J Clin Exp Pathol       Date:  2018-09-01

5.  Skp2-mediated ubiquitination and mitochondrial localization of Akt drive tumor growth and chemoresistance to cisplatin.

Authors:  Xinfang Yu; Ruike Wang; Yangnan Zhang; Li Zhou; Wei Wang; Haidan Liu; Wei Li
Journal:  Oncogene       Date:  2019-08-21       Impact factor: 9.867

Review 6.  Targeting the signaling in Epstein-Barr virus-associated diseases: mechanism, regulation, and clinical study.

Authors:  Ya Cao; Longlong Xie; Feng Shi; Min Tang; Yueshuo Li; Jianmin Hu; Lin Zhao; Luqing Zhao; Xinfang Yu; Xiangjian Luo; Weihua Liao; Ann M Bode
Journal:  Signal Transduct Target Ther       Date:  2021-01-12

7.  Tumor-derived exosomal microRNA-106b-5p activates EMT-cancer cell and M2-subtype TAM interaction to facilitate CRC metastasis.

Authors:  Chaogang Yang; Rongzhang Dou; Chen Wei; Keshu Liu; Dongdong Shi; Chunxiao Zhang; Qing Liu; Shuyi Wang; Bin Xiong
Journal:  Mol Ther       Date:  2021-02-09       Impact factor: 12.910

8.  Down-regulation of miR-26b induces cisplatin resistance in nasopharyngeal carcinoma by repressing JAG1.

Authors:  Lei Shi; Wei Yin; Zhiyu Zhang; Guanggang Shi
Journal:  FEBS Open Bio       Date:  2016-10-24       Impact factor: 2.693

9.  Dysregulation of the MiR-449b target TGFBI alters the TGFβ pathway to induce cisplatin resistance in nasopharyngeal carcinoma.

Authors:  Pierre-Antoine Bissey; Jacqueline H Law; Jeff P Bruce; Wei Shi; Aline Renoult; Melvin L K Chua; Kenneth W Yip; Fei-Fei Liu
Journal:  Oncogenesis       Date:  2018-05-22       Impact factor: 7.485

10.  Programmed cell death 4 modulates lysosomal function by inhibiting TFEB translation.

Authors:  Xiaotong Chen; Yetong Guan; Yi Zhang; Yufeng Jia; Wen Li; Chun Guo; Yuan Li; Xiaoyan Wang; Yongyu Shi; Qun Wang; Faliang Zhu; Yan Li; Lining Zhang
Journal:  Cell Death Differ       Date:  2020-10-25       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.